KARL KAISER: Open Payments
NPI 1902315997 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 47 payments from 5 companies in 2025. Trend: 2023 $101 · 2024 $229 · 2025 $593
Food & beverage: $498Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $375 |
| Janssen Biotech, Inc. | 4 | $116 |
| Corcept Therapeutics | 3 | $52 |
| Novo Nordisk Inc | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $19 |
Products named: VRAYLAR, TREMFYA, UBRELVY, QULIPTA, Korlym, LINZESS, Wegovy, CREON.
Industry payments across OH — which companies pay providers there.
